ISSN 0300-9092 (Print)
ISSN 2412-5679 (Online)

The risk of epigenetic changes in children born after assisted reproductive technologies

Pitskhelauri E.G., Ignatko I.V., Timokhina E.V., Kuzmina T.E., Bogomazova I.M., Belousova V.S., Gorbunova V.A., Totchiev G.F., Churganova A.A., Pashkov V.M., Lebedev V.A., Kardanova M.A., Fedyunina I.A.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University), Moscow, Russia

Assisted reproductive technologies (ART) involve chemical and physical manipulations of gametes, the induction of non-physiological levels of gonadotropins, in vitro fertilization, cultivation, freezing and transfer of embryos under artificial conditions. Some studies suggest that children conceived by ART are at a higher risk of hypotrophy, neonatal complications and congenital malformations compared with naturally conceived children. One of the most relevant and controversial issues is epigenetic changes in children born after ART. According to some authors, epigenetic disorders such as Beckwith–Wiedemann syndrome, Angelman syndrome, Prader–Willi syndrome and Silver–Russell syndrome are associated with assisted reproduction. Epigenetics is basically a set of mechanisms that regulate gene expression in various cells of the body, thereby determining their functions. Epigenetic mechanisms are realized through DNA methylation, histone modifications or RNA-mediated (transcriptional) mechanisms. One special mechanism of epigenetics involves imprinted genes, the expression of which is determined by whether the chromosome is of maternal or paternal origin. These genes largely determine the processes of embryonic and intrauterine development and placentation, as well as the distribution of resources for fetal growth. Why is it so important to consider the potential impact of ART on epigenetics? Precisely because, during the formation of the primordial germ cell line and subsequently during implantation, global demethylation occurs (that is, the removal of all these methyl marks, both in imprinted and other genes) and new marks are established. In vitro cultivation, freezing and embryo transfer under artificial conditions occur during the period when the epigenome is most vulnerable to errors. This raises a number of questions: is the use of ART the underlying cause of epigenetic changes, or are there factors that may mediate the effect of these methods on the epigenome?     
Conclusion. Assisted reproduction is associated with epigenetic changes, but the effects of these technologies are mediated by many other factors. Epigenetic changes may be stochastic and mosaic in nature. The age of patients and conditions leading to infertility increase these risks. It is necessary to continue closely monitoring children born after ART in order to identify any potential consequences of this method of treating infertility.

Authors’ contribution. Ignatko I.V., Lebedev V.A., Pashkov V.M., Pitskhelauri E.G., Timokhina E.V. – developing the concept behind the review topic; Pitskhelauri E.G., Gorbunova V.A., Kuzmina T.E., Fedyunina I.A., Churganova A.A. – collecting and processing information; Pitskhelauri E.G., Gorbunova V.A., Kardanova M.A., Bogomazova I.M. – writing the text; Ignatko I.V., Timokhina E.V., Belousova V.S., Gorbunova V.A., Totchiev G.F., Pitskhelauri E.G. – editing the article.
Conflicts of interest. The authors declare that there are no conflicts of interest.
Funding. The study was conducted without sponsorship.
Generative Artificial Intelligence. Generative AI technologies were not used in preparing this article.
For citation: Pitskhelauri E.G., Ignatko I.V., Timokhina E.V., Kuzmina T.E., Bogomazova I.M., Belousova V.S., Gorbunova V.A., Totchiev G.F., Churganova A.A., Pashkov V.M., Lebedev V.A., Kardanova M.A., Fedyunina I.A.
The risk of epigenetic changes in children born after assisted reproductive technologies. 
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2026; (7): 48-56 (in Russian)
https://dx.doi.org/10.18565/aig.2025.357

Keywords

assisted reproductive technologies
epigenetic changes
neonatal complications
DNA methylation
in vitro fertilization
children’s health

References

  1. Мотренко Т. Вспомогательные репродуктивные технологии и риск эпигенетического перепрограммирования у потомства. Проблемы репродукции. 2016; 22(4): 52‑9. https://dx.doi.org/10.17116/repro201622452-59 [Motrenko T. The risks of epigenetic reprogramming in children conceived by assisted reproductive technologies. Russian Journal of Human Reproduction. 2016; 22(4): 52-9 (in Russian) https://dx.doi.org/10.17116/repro201622452-59].
  2. Беляева И.А., Намазова-Баранова Л.С., Баранов А.А., Эфендиева К.Е., Каркашадзе Г.А., Дедюкина Е.С., Серебрякова Е.Н., Константиниди Т.А., Гогберашвили Т.Ю., Молодченков А.И. Отдаленное развитие и здоровье детей, зачатых с помощью вспомогательных репродуктивных технологий. Вопросы современной педиатрии. 2022; 21(2): 72-82. https://dx.doi.org/10.15690/pf.v19i2.2404 [Belyaeva I.А., Namazova-Baranova L.S., Baranov A.A., Efendieva K.Y., Karkashadze G.A., Dedyukina E.S., Serebryakova E.N., Konstantinidi T.A., Gogberashvili T.Yu., Molodchenkov A.I. Long-term development and health of children conceived by assisted reproductive technologies. Current Pediatrics. 2022; 21(2): 72-82 (in Russian). https://dx.doi.org/10.15690/pf.v19i2.2404].
  3. Пицхелаури Е.Г., Стрижаков А.Н., Тимохина Е.B., Белоусова В.С., Богомазова И.М., Гарина А.О. Здоровье детей после вспомогательных репродуктивных технологий: вероятные риски и возможные осложнения. Акушерство, гинекология и репродукция. 2018; 12(3): 56-63. https://dx.doi.org/10.17749/2313-7347.2018.12.3.056-063 [Pitskhelauri E.G., Strizhakov A.N., Timokhina E.B., Belousova V.S., Bogomazova I.M., Garina A.O. The health status of children born through assisted reproductive technologies: probable risks and possible complications. Obstetrics, Gynecology and Reproduction. 2018; 12(3): 56-63 (in Russian). https://dx.doi.org/10.17749/2313- 7347.2018.12.3.056-063].
  4. Sciorio R., Tramontano L., Rapalini E., Bellaminutti S., Bulletti F.M., D'Amato A. et al. Risk of genetic and epigenetic alteration in children conceived following ART: Is it time to return to nature whenever possible? Clin. Genet. 2023; 103(2): 133-45. https://dx.doi.org/10.1111/cge.14232
  5. Sciorio R., Campos G., Tramontano L., Bulletti F.M., Baldini G.M., Vinciguerra M. Exploring the effect of cryopreservation in assisted reproductive technology and potential epigenetic risk. Zygote. 2023; 31(5): 420-32. https://dx.doi.org/10.1017/S0967199423000345
  6. Hattori H., Hiura H., Kitamura A., Miyauchi N., Kobayashi N., Takahashi S. et al. Association of four imprinting disorders and ART. Clin. Epigenetics. 2019; 11(1): 21. https://dx.doi.org/10.1186/s13148-019-0623-3
  7. Cortessis V.K., Azadian M., Buxbaum J., Sanogo F., Song A.Y., Sriprasert I. et al. Comprehensive meta-analysis reveals association between multiple imprinting disorders and conception by assisted reproductive technology. J. Assist. Reprod. Genet. 2018; 35(6): 943-52. https://dx.doi.org/10.1007/s10815-018-1173-x
  8. Cannarella R., Crafa A., Mongioì L.M., Leggio L., Iraci N., La Vignera S. et al. DNA methylation in offspring conceived after assisted reproductive techniques: a systematic review and meta-analysis. J. Clin. Med. 2022; 11(17): 5056. https://dx.doi.org/10.3390/jcm11175056
  9. Sciorio R., Tramontano L., Rapalini E., Bellaminutti S., Bulletti F.M., D'Amato A. et al. Risk of genetic and epigenetic alteration in children conceived following ART: is it time to return to nature whenever possible? Clin. Genet. 2023; 103(2): 133-43. https://dx.doi.org/10.1111/cge.14232
  10. Moutinho C., Esteller M. MicroRNAs and epigenetics. Adv. Cancer Res. 2017; 135: 189-220. https://dx.doi.org/10.1016/bs.acr.2017.06.003
  11. Ochoa E. Alteration of genomic imprinting after assisted reproductive technologies and long-term health. Life (Basel). 2021; 11(8): 728. https://dx.doi.org/10.3390/life11080728
  12. Zhang G., Mao Y., Zhang Y., Huang H., Pan J. Assisted reproductive technology and imprinting errors: analyzing underlying mechanisms from epigenetic regulation. Hum. Fertil. (Camb). 2023; 26(4): 864-78. https://dx.doi.org/10.1080/14647273.2023.2261628
  13. Sciorio R., El Hajj N. Epigenetic risks of medically assisted reproduction. J. Clin. Med. 2022; 11(8): 2151. https://dx.doi.org/10.3390/jcm11082151
  14. Kagami M., Hara-Isono K., Sasaki A., Amita M. Association between imprinting disorders and assisted reproductive technologies. Epigenomics. 2025; 17(6): 397-410. https://dx.doi.org/10.1080/17501911.2025.2471269
  15. Choux C., Binquet C., Carmignac V., Bruno C., Chapusot C., Barberet J. et al. The epigenetic control of transposable elements and imprinted genes in newborns is affected by the mode of conception: ART versus spontaneous conception without underlying infertility. Hum. Reprod. 2018; 33(2): 331-40. https://dx.doi.org/10.1093/humrep/dex366
  16. Litzky J.F., Deyssenroth M.A., Everson T.M., Armstrong D.A., Lambertini L., Chen J. et al. Placental imprinting variation associated with assisted reproductive technologies and subfertility. Epigenetics. 2017; 12(8): 653-61. https://dx.doi.org/10.1080/15592294.2017.1336589
  17. Auvinen P., Vehviläinen J., Rämö K., Laukkanen I., Marjonen-Lindblad H., Wallén E. et al. Genome-wide DNA methylation and gene expression in human placentas derived from assisted reproductive technology. Commun. Med. (Lond). 2024; 4: 267. https://dx.doi.org/10.1038/s43856-024-00694-6
  18. Sundrani D., Kapare A., Yadav H., Randhir K., Gupte S., Joshi S. Placental expression and methylation of angiogenic factors in assisted reproductive technology pregnancies from India. Epigenomics. 2025; 17(1): 21-31. https://dx.doi.org/10.1080/17501911.2024.2438593
  19. Fauque P., De Mouzon J., Devaux A., Epelboin S., Gervoise-Boyer M.J., Levy R. et al. Reproductive technologies, female infertility, and the risk of imprinting-related disorders. Clin. Epigenet. 2020; 12(1): 191. https://dx.doi.org/10.1186/s13148-020-00986-3
  20. Nuzzo A.M., Canosa S., Dalmasso P., Borbon C., Sestero M., Evangelisti B. et al. Differential effects of assisted reproduction technology on placental epigenetics and angiogenesis: insights from fresh, frozen, and egg donation pregnancies. Life (Basel). 2025; 15(12): 1882. https://dx.doi.org/10.3390/life15121882
  21. Kindsfather A.J., Czekalski M.A., Pressimone C.A., Erisman M.P., Mann M.R.W. Perturbations in imprinted methylation from assisted reproductive technologies but not advanced maternal age in mouse preimplantation embryos. Clin. Epigenet. 2019; 11(1): 162. https://dx.doi.org/10.1186/s13148-019-0751-9
  22. Lloyd D.T., Skinner H.G., Maguire R., Murphy S.K., Motsinger-Reif A.A., Hoyo C. et al. Clomifene and assisted reproductive technology in humans are associated with sex-specific offspring epigenetic alterations in imprinted control regions. Int. J. Mol. Sci. 2022; 23(18): 10450. https://dx.doi.org/10.3390/ijms231810450
  23. Gentilini D., Somigliana E., Pagliardini L., Rabellotti E., Garagnani P., Bernardinelli L. et al. Multifactorial analysis of the stochastic epigenetic variability in cord blood confirmed an impact of common behavioral and environmental factors but not of in vitro conception. Clin. Epigenet. 2018; 10: 77. https://dx.doi.org/10.1186/s13148-018-0510-3
  24. Haertle L., El Hajj N., Dittrich M., Müller T., Nanda I., Lehnen H. et al. Epigenetic signatures of gestational diabetes mellitus on cord blood methylation. Clin. Epigenet. 2017; 9: 28. https://dx.doi.org/10.1186/s13148-017-0329-3
  25. Melamed N., Pnueli L., Mor-Dror A., Martel J., Bérard A., Fraser W.D. et al. Capturing sex-specific and hypofertility-linked effects of assisted reproductive technologies on the cord blood DNA methylome. Clin. Epigenet. 2023; 15: 82. https://dx.doi.org/10.1186/s13148-023-01497-7
  26. Schaub A.M., Gonzalez T.L., Dorfman A.E., Novoa A.G., Hussaini R.A., Harakuni P.M. et al. A systematic review of genome-wide analyses of methylation changes associated with assisted reproductive technologies in various tissues. Fertil. Steril. 2024; 121(1): 80-94. https://dx.doi.org/10.1016/j.fertnstert.2023.10.007
  27. Cortessis V.K., Azadian M., Buxbaum J., Sanogo F., Song A.Y., Sriprasert I. et al. Comprehensive meta-analysis reveals association between multiple imprinting disorders and conception by assisted reproductive technology. J. Assist. Reprod. Genet. 2018; 35(6): 943-52. https://dx.doi.org/10.1007/s10815-018-1173-x
  28. Greenberg M.V.C., Bourc'his D. The diverse roles of DNA methylation in mammalian development and disease. Nat. Rev. Mol. Cell. Biol. 2019; 20(10): 590-607. https://dx.doi.org/10.1038/s41580-019-0159-6
  29. Karahan G., Martel J., Rahimi S., Farag M., Matias F., MacFarlane A.J. et al. Higher incidence of embryonic defects in mouse offspring conceived with assisted reproduction from fathers with sperm epimutations. Hum. Mol. Genet. 2023; 33(1): 48-63. https://dx.doi.org/10.1093/hmg/ddad160
  30. Chan D., Shao X., Dumargne M.C., Aarabi M., Simon M.M., Kwan T. et al. Customized methylC-capture sequencing to evaluate variation in the human sperm DNA methylome representative of altered folate metabolism. Environ. Health Perspect. 2019; 127(8): 87002. https://dx.doi.org/10.1289/EHP4812
  31. Choufani S., Turinsky A.L., Melamed N., Greenblatt E., Brudno M., Bérard A. et al.; 3D cohort study group. Impact of assisted reproduction, infertility, sex and paternal factors on the placental DNA methylome. Hum. Mol. Genet. 2019; 28(3): 372-85. https://dx.doi.org/10.1093/hmg/ddy321
  32. Rahimi S., Shao X., Chan D., Martel J., Bérard A., Fraser W.D. et al. Capturing sex-specific and hypofertility-linked effects of assisted reproductive technologies on the cord blood DNA methylome. Clin. Epigenetics. 2023; 15(1): 82. https://dx.doi.org/10.1186/s13148-023-01497-7
  33. Narapareddy L., Rhon-Calderon E.A., Vrooman L.A., Baeza J., Nguyen D.K., Mesaros C. et al. Sex-specific effects of in vitro fertilization on adult metabolic outcomes and hepatic transcriptome and proteome in mouse. FASEB J. 2021; 35(4): e21523. https://dx.doi.org/10.1096/fj.202002744R
  34. Kristjansson D., Lee Y., Page C.M., Gjessing H., Magnus M.C., Jugessur A. et al. Sex differences in DNA methylation variations according to ART conception-evidence from the Norwegian mother, father, and child cohort study. Sci Rep. 2024; 14(1): 22904. https://dx.doi.org/10.1038/s41598-024-73845-3
  35. Shah J.B., Pueschl D., Wubbenhorst B., Fan M., Pluta J., D'Andrea K. et al. Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers. Nat Commun. 2022; 13(1): 6728. https://dx.doi.org/10.1038/s41467-022-34523-y
  36. Glodzik D., Bosch A., Hartman J., Aine M., Vallon-Christersson J., Reuterswärd C. et al. Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers. Nat. Commun. 2020;11(1): 3747. https://dx.doi.org/10.1038/s41467-020-17537-2
  37. Nikolaienko O., Eikesdal H.P., Ognedal E., Gilje B., Lundgren S., Blix E.S. et al. Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development. Genome Med. 2023; 15(1): 104. https://dx.doi.org/10.1186/s13073-023-01262-8
  38. Romanowska J., Nustad H.E., Page C.M., Denault W.R.P., Lee Y., Magnus M.C. et al. The X-factor in ART: does the use of assisted reproductive technologies influence DNA methylation on the X chromosome? Hum. Genomics. 2023; 17(1): 35. https://dx.doi.org/10.1186/s40246-023-00484-6
  39. Li F., Yuan P., Rao M., Jin C.H., Tang W., Rong Y.F. et al. piRNA-independent function of PIWIL1 as a co-activator for anaphase promoting complex/cyclosome to drive pancreatic cancer metastasis. Nat. Cell. Biol. 2020; 22(4): 425-38. https://dx.doi.org/10.1038/s41556-020-0486-z
  40. Casanova-Acebes M., Menéndez-Gutiérrez M.P., Porcuna J., Álvarez-Errico D., Lavin Y., García A. et al. RXRs control serous macrophage neonatal expansion and identity and contribute to ovarian cancer progression. Nat. Commun. 2020; 11(1): 1655. https://dx.doi.org/10.1038/s41467-020-15371-0
  41. Mzoughi S., Fong J.Y., Papadopoli D., Koh C.M., Hulea L., Pigini P. et al. PRDM15 is a key regulator of metabolism critical to sustain B-cell lymphomagenesis. Nat. Commun. 2020; 11(1): 3520. https://dx.doi.org/10.1038/s41467-020-17064-0
  42. Marshall K.L., Rivera R.M. The effects of superovulation and reproductive aging on the epigenome of the oocyte and embryo. Mol. Reprod. Dev. 2018; 85(2): 90-105. https://dx.doi.org/10.1002/mrd.22951
  43. Choux C., Binquet C., Carmignac V., Bruno C., Chapusot C., Barberet J. et al. The epigenetic control of transposable elements and imprinted genes in newborns is affected by the mode of conception: ART versus spontaneous conception without underlying infertility. Hum. Reprod. 2018; 33(2): 331-40. https://dx.doi.org/10.1093/humrep/dex366
  44. Hara-Isono K., Matsubara K., Mikami M., Arima T., Ogata T., Fukami M. et al. Assisted reproductive technology represents a possible risk factor for development of epimutation-mediated imprinting disorders for mothers aged ≥30 years. Clin. Epigenet. 2020; 12(1): 111. https://dx.doi.org/10.1186/s13148-020-00900-x

Received 05.12.2025

Accepted 25.06.2026

About the Authors

Elena G. Pitskhelauri, PhD, Associate Professor, Associate Professor at the Department of Obstetrics, Gynecology and Perinatology, Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University), 119991, Russia, Moscow, Trubetskaya str., 8, bldg. 2,
+7(916)334-00-89, pitskhelauri_e_g@staff.sechenov.ru, https://orcid.org/0000-0002-9634-1541
Irina V. Ignatko, Dr. Med. Sci., Corresponding Member of the Russian Academy of Sciences, Professor of the Russian Academy of Sciences, Professor, Head of the Department of Obstetrics, Gynecology, and Perinatology, Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University), 119991, Russia, Moscow, Trubetskaya str., 8, bldg. 2, ignatko_i_v@staff.sechenov.ru, https://orcid.org/0000-0002-9945-3848
Elena V. Timokhina, Dr. Med. Sci., Associate Professor, Professor at the Department of Obstetrics, Gynecology, and Perinatology, Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University), 119991, Russia, Moscow, Trubetskaya str., 8, bldg. 2, timokhina_e_v@staff.sechenov.ru, https://orcid.org/0000-0001-6628-0023
Tatiana E. Kuzmina, PhD, Associate Professor, Associate Professor at the Department of Obstetrics, Gynecology and Perinatology, Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University), 119991, Russia, Moscow, Trubetskaya str., 8, bldg. 2,
kuzmina_t_e@staff.sechenov.ru, https://orcid.org/0000-0001-9649-5383
Irina M. Bogomozova, PhD, Associate Professor, Associate Professor at the Department of Obstetrics, Gynecology and Perinatology, Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University), 119991, Russia, Moscow, Trubetskaya str., 8, bldg. 2, +7(926)305-04-03, bogomazova_i_m@staff.sechenov.ru, https://orcid.org/0000-0003-1156-7726
Vera S. Belousova, Dr. Med. Sci., Associate Professor, Professor at the Department of Obstetrics, Gynecology and Perinatology, Sklifosovsky Institute of Clinical Medicine,
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University), 119991, Russia, Moscow, Trubetskaya str., 8, bldg. 2, belousova_v_s@staff.sechenov.ru, https://orcid.org/0000-0001-8332-7073
Violetta A. Gogbunova, student at Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
(Sechenov University), 119991, Russia, Moscow, Trubetskaya str., 8, bldg. 2, violagorbunova.03@mail.ru, https://orcid.org/0009-0001-6105-9060
Georgi F. Totchiev, Dr. Med. Sci., Associate Professor, Professor at the Department of Obstetrics, Gynecology and Perinatology, Sklifosovsky Institute of Clinical Medicine,
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University), 119991, Russia, Moscow, Trubetskaya str., 8, bldg. 2,
totchiev_g_f@staff.sechenov.ru, https://orcid.org/0000-0001-6830-2548
Anastasia A. Churganova, PhD, Associate Professor at the Department of Obstetrics, Gynecology and Perinatology, Sklifosovsky Institute of Clinical Medicine,
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University), 119991, Russia, Moscow, Trubetskaya str., 8, bldg. 2,
churganova_a_a@staff.sechenov.ru, https://orcid.org/0000-0001-9398-9900
Vladimir M. Pashkov, Dr. Med. Sci., Professor at the Department of Obstetrics, Gynecology and Perinatology, Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University), 119991, Russia, Moscow, Trubetskaya str., 8, bldg. 2, pashkov_v_m@staff.sechenov.ru, https://orcid.org/0000-0003-3768-7822
Vladimir A. Lebedev, Dr. Med. Sci., Professor at the Department of Obstetrics, Gynecology and Perinatology, Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University), 119991, Russia, Moscow, Trubetskaya str., 8, bldg. 2, lebedev_v_a@staff.sechenov.ru, https://orcid.org/0000-0002-3302-5533
Madina A. Kardanova, PhD, Associate Professor at the Department of Obstetrics, Gynecology and Perinatology, Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University), 119991, Russia, Moscow, Trubetskaya str., 8, bldg. 2, kardanova_m_a@staff.sechenov.ru, https://orcid.org/ 0000-0002-4315-0717
Irina A. Fedyunina, PhD, Associate Professor at the Department of Obstetrics, Gynecology, and Perinatology, Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University), Moscow, Russian Federation, 119991, Russia, Moscow, Trubetskaya str., 8, bldg. 2, fedyunina_i_a@staff.sechenov.ru, https://orcid.org/0000-0002-9661-5338

Similar Articles